LY4005130
/ Eli Lilly, Samsung
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 28, 2026
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
(clinicaltrials.gov)
- P2 | N=60 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Dermatology • Immunology • Vitiligo
April 17, 2026
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
(clinicaltrials.gov)
- P2 | N=60 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P2 trial • Dermatology • Immunology • Vitiligo
1 to 2
Of
2
Go to page
1